Peptide LexiconAll compounds

Nisin: The 34-Amino-Acid Bacterial Peptide Used to Keep Cheese Spreads Safe — What It Is and What the Record Shows

Nisin is a 34-amino-acid antimicrobial peptide made by the bacterium Lactococcus lactis. It belongs to the lantibiotics, peptides tied into rings by sulfur bridges. In the US it is listed as generally recognised as safe for one named use: stopping botulinum spores from growing in pasteurised cheese spreads. It is not an approved medicine.

Food preservative (US GRAS listing, 21 CFR 184.1538)Not an approved medicineFew human trials

Caroline S · Published 2026-11-12

Length

34 amino acids, about 3.4 kDa, with five (methyl)lanthionine rings (Biotechnol Lett 2005, PMID 16247668); PubChem CID 16129667 gives C143H230N42O37S7, molecular weight 3,354.1

Sequence

Not an ordinary linear sequence: after the chain is made, several residues are dehydrated and five thioether (lanthionine and methyl-lanthionine) bridges close it into rings, and the finished peptide contains the unusual amino acids dehydroalanine and dehydrobutyrine

Origin

Natural: made on the ribosome by strains of the lactic-acid bacterium Lactococcus lactis (formerly Streptococcus lactis), then modified by enzymes coded in a cluster of 11 genes (PMID 16247668). The US regulation describes a preparation from pure-culture fermentation.

Last reviewed

2026-11-12

What is it good for?

Preserving food. Its US listing names one use — an antimicrobial to inhibit the outgrowth of Clostridium botulinum spores and toxin formation in pasteurised cheese spreads and process cheese spreads, at no more than 250 parts per million of nisin in the finished product (21 CFR 184.1538). Its antibacterial activity has also been studied in mouth-care gels and in cancer research, none of it an approved medical use.

Illustration: A clear glass flask with pale green liquid on a white lab bench with a copper reflection.
Illustration

What it is

Nisin is an antimicrobial peptide that bacteria make to kill other bacteria, and food makers use it to keep certain foods safe. A 2005 review describes it as "a small (3.4 kDa), 34-amino acid, cationic, hydrophobic peptide" produced by strains of the lactic-acid bacterium Lactococcus lactis (PMID 16247668). PubChem's record (CID 16129667) gives the formula C143H230N42O37S7 and a molecular weight of 3,354.1.

What makes it unusual is its shape. The chain is made on the ribosome like any protein fragment, then enzymes dehydrate several residues and tie five sulfur bridges across it, locking it into rings. Those bridges create the rare amino acid lanthionine, which gives the whole class its name: the lantibiotics. The same review counts 11 genes in the cluster that builds it.

How it works

A 1999 review in Biochimica et Biophysica Acta (PMID 10590310) describes nisin as a 34-residue group A lantibiotic "with antimicrobial activity against Gram-positive bacteria," active in the nanomolar range, and notes that its dehydrated residues and rings restrict its shape — which is why its mode of action became a research subject in its own right. The practical point for food is the target the US listing names: the spore-forming, Gram-positive Clostridium botulinum. This entry has read the reviews' abstracts, not their full mechanism sections, and does not describe the molecular steps.

Gram-positive bacteria carry a thick wall made of sugars cross-linked by short peptides, explained in the peptidoglycan entry.

What the US regulation says

Nisin's US standing is a food-ingredient listing, not a drug approval. 21 CFR 184.1538 (eCFR, current to 2026-11-09) reads, in summary:

Part of the rule What it says
Source Pure-culture fermentations of certain strains of Streptococcus lactis Lancefield Group N (the older name for Lactococcus lactis)
Identity Nisin, CAS 1414-45-5, "a group of related peptides with antibiotic activity"
Strength Not less than 900 international units per milligram
Purity Arsenic ≤1 ppm, lead ≤2 ppm, zinc ≤25 ppm, zinc plus copper ≤50 ppm; Salmonella, E. coli and coagulase-positive staphylococci absent in 10 g
Use named Inhibiting C. botulinum spore outgrowth and toxin formation in pasteurised cheese spreads and process cheese spreads (with or without fruits, vegetables or meats)
Level Good manufacturing practice, defined as the quantity delivering a maximum of 250 parts per million of nisin in the finished product

Two limits on reading this. The listing names one food category; other foods have reached the US market through separate GRAS notices, which this entry has not opened and does not count. And a GRAS listing is a finding about that use at that level, not a general statement about nisin in other forms.

What has been tested in people

Very little, compared with its long use in food. Of 3,130 PubMed records with nisin in the title or abstract, 6 are tagged as randomised controlled trials (2026-11-12). ClinicalTrials.gov lists 5 records; three test nisin-containing products directly:

Record What it tests Status (2026-11-12)
NCT05975177 A gel after scaling and root planing in periodontitis Completed
NCT07088679 A "natural bioactive gel" for peri-implantitis Recruiting
NCT06097468 Nisin in oral cavity squamous cell carcinoma Recruiting

No result from these records has led to an approved medical use. The cancer interest comes from laboratory studies; a recruiting trial is a question being asked, not an answer.

Where it stands

  • Food: listed as GRAS in the US for pasteurised cheese spreads (21 CFR 184.1538).
  • Medicine: not approved anywhere this entry has checked; the medical record is laboratory work plus a handful of trials.
  • Research record: PubMed 3,130 records, 6 randomised trials; ClinicalTrials.gov 5 records (2026-11-12).

Other bacterial peptides used as antibiotics in the library include bacitracin, polymyxin B and gramicidin, which forms ion channels in bacterial membranes. The human body makes antimicrobial peptides of its own: LL-37 and the defensin family of human antibiotic peptides. Another soil-bacterium peptide, surfactin, works through a ring and a fatty tail rather than sulfur bridges. For the food-ingredient side of the library, see casein phosphopeptide and the dipeptide sweetener neotame.

What the research shows

Kills or blocks Gram-positive bacteria

Laboratory and food-science record, described in reviews (e.g. PMID 16247668); the basis of its use as a preservative

Safe as a food ingredient at the listed use

US GRAS listing for pasteurised cheese spreads (21 CFR 184.1538, eCFR current to 2026-11-09)

Treats gum disease or other oral infections

Registered trials only: NCT05975177 (periodontitis gel, completed), NCT07088679 (peri-implantitis gel, recruiting); PubMed tags 6 nisin records as randomised controlled trials (2026-11-12)

Has anticancer activity

Laboratory studies; one registered trial, NCT06097468 in oral cavity squamous cell carcinoma, recruiting (ClinicalTrials.gov, 2026-11-12)

Bars show how much of the evidence is in humans, not how well anything works.

Where it stands

United States

Listed as a direct food substance affirmed as generally recognised as safe, 21 CFR 184.1538, for pasteurised cheese spreads and process cheese spreads (eCFR, current to 2026-11-09). Not an FDA-approved drug.

Specification

Not less than 900 international units per milligram; limits on arsenic, lead, zinc and copper; Salmonella, E. coli and coagulase-positive staphylococci absent in 10 g (21 CFR 184.1538).

Published record

PubMed: 3,130 records with nisin in the title or abstract, 6 tagged as randomised controlled trials; ClinicalTrials.gov: 5 records (2026-11-12).

Frequently asked questions

Is nisin a peptide?

Yes. It is a 34-amino-acid peptide made on the ribosome by the bacterium Lactococcus lactis, then reshaped by enzymes into a chain with five sulfur-bridged rings. That family of ring-locked peptides is called the lantibiotics.

What is nisin used for?

As a food preservative. Its US listing, 21 CFR 184.1538, names its use in pasteurised cheese spreads and process cheese spreads, to stop botulinum spores from growing and producing toxin, at up to 250 parts per million in the finished product.

Is nisin an antibiotic?

It is an antimicrobial peptide, and the US regulation describes nisin as a group of related peptides with antibiotic activity. It is not an approved antibiotic medicine; its regulated use is in food.

Is nisin safe?

In the US it is listed as generally recognised as safe for the cheese-spread use named in 21 CFR 184.1538, at the level that regulation sets. That listing covers that food use; it is not a finding about any other use, dose or product.

Has nisin been tested in people as a medicine?

Only in small numbers. PubMed tags 6 nisin records as randomised controlled trials, and ClinicalTrials.gov lists a completed periodontitis gel study, a recruiting peri-implantitis gel study and a recruiting oral-cancer study (read 2026-11-12). None has led to an approved medical use.

What is a lantibiotic?

A peptide antimicrobial made by bacteria whose chain is locked into rings by thioether bridges containing the unusual amino acid lanthionine — the source of the name. Nisin is the best-characterised member and, per a 2005 review, has five such rings.